UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000038318
Receipt number R000043675
Scientific Title A Study on the efficacy of plant extracts for physical effect.
Date of disclosure of the study information 2019/10/23
Last modified on 2020/04/17 15:32:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy test of plant extracts for physical effect.

Acronym

Efficacy test of plant extracts for physical effect.

Scientific Title

A Study on the efficacy of plant extracts for physical effect.

Scientific Title:Acronym

Efficacy test of plant extracts for physical effect.

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To confirm the effect for physiological responses by physical therapy for healthy male

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Evaluation of the skin blood flow after the treatment with plant extracts.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

4

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Control sample application > wash out (24 h) > test sample A application > wash out (24 h) > test sample B application > wash out (24 h) > test sample C application

Interventions/Control_2

Test sample A application > wash out (24 h) > test sample B application > wash out (24 h) > test sample C application > wash out (24 h) > control sample application

Interventions/Control_3

Test sample B application > wash out (24 h) > test sample C application > wash out (24 h) > control sample application > wash out (1 da24 h y) > test sample A application

Interventions/Control_4

Test sample C application > wash out (24 h) > control sample application > wash out (24 h) > test sample A application > wash out (24 h) > test sample B application

Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

59 years-old >=

Gender

Male

Key inclusion criteria

Healthy males

Key exclusion criteria

-Smokers
-Subjects with hypertension, heart disease, diabetes mellitus and Raynaud's disease
-Subjects with atopic dermatitis, eczema and pollen allergy

Target sample size

15


Research contact person

Name of lead principal investigator

1st name Yasuo
Middle name
Last name Toyoshima

Organization

Kao Corporation

Division name

Personal Health Care Products Research

Zip code

131-8501

Address

2-1-3, Bunka, Sumida-ku, Tokyo 131-8501, Japan

TEL

03-5630-7281

Email

toyoshima.yasuo@kao.com


Public contact

Name of contact person

1st name Yuichi
Middle name
Last name Tanabe

Organization

Kao Corporation

Division name

Personal Health Care Products Research

Zip code

131-8501

Address

2-1-3, Bunka, Sumida-ku, Tokyo 131-8501, Japan

TEL

03-5630-9971

Homepage URL


Email

tanabe.yuichi@kao.com


Sponsor or person

Institute

Kao Corporation

Institute

Department

Personal name



Funding Source

Organization

Kao Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Human Research Ethics Committee, Kao Corporation

Address

2-1-3, Bunka, Sumida-ku, Tokyo 131-8501, Japan

Tel

+81-3-5630-7263

Email

morisaki.naoko@kao.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

花王株式会社(東京都)


Other administrative information

Date of disclosure of the study information

2019 Year 10 Month 23 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 09 Month 27 Day

Date of IRB

2019 Year 09 Month 27 Day

Anticipated trial start date

2019 Year 10 Month 25 Day

Last follow-up date

2019 Year 11 Month 29 Day

Date of closure to data entry

2019 Year 12 Month 25 Day

Date trial data considered complete

2019 Year 12 Month 25 Day

Date analysis concluded

2020 Year 01 Month 31 Day


Other

Other related information



Management information

Registered date

2019 Year 10 Month 17 Day

Last modified on

2020 Year 04 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043675


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name